Silencing of HIV-1 Proviruses (R61/R33)
| קרן | National Institutes of Health (NIH) |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 06/11/2017 |
| פקולטה | Life Sciences, Medicine |
| תיאור | This grant encourages exploratory and developmental bi-phasic research applications to support the identification and optimization of small molecules or RNAs that interact with host epigenetic machinery to mediate long-term or permanent epigenetic silencing of HIV-1 proviruses.
Funding: $500,000 per year Duration 5 years (3 for R61+ 2 for R33)
Research Authority due date: 1.11.17 LOI (encouraged) due date: 6.11.17 Full proposal due date: 6.12.17 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 18/05/2017 |
